Where Members Showcase their Work! Publication Corner
Submission by Gabriel Levin Pembrolizumab or placebo with chemoradiotherapy Followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Submission by Katie McRae Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Submission by Cristina Mitric Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
Made with FlippingBook - PDF hosting